Sobi To Appeal Against EMA Rejection For Emapalumab

business
Sobi plans to share its inights and address the CHMP's questions about Gamifant • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet